PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Clinical Liver Disease10.1002/cld.26201214114-116Assessment and management of comorbidities (including cardiovascular disease) in patients with nonalcoholic fatty liver diseaseKathleen E. Corey, Raj Vuppalanchihttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcld.26, http://onlinelibrary.wiley.com/wol1/doi/10.1002/cld.26/fullpdf
Liver Transplantation10.1002/lt.250032018242166-170Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Implications for liver transplantationZobair M. Younossihttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Flt.25003, https://journals.lww.com/01445473-201802000-00005
Clinical Liver Disease10.1002/cld.66201214129-130Management of nonalcoholic fatty liver disease in childrenJean P. Mollestonhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcld.66, http://onlinelibrary.wiley.com/wol1/doi/10.1002/cld.66/fullpdf
Clinical Liver Disease10.1002/cld.65201214104-107Nonalcoholic fatty liver disease: Indications for liver biopsy and noninvasive biomarkersMazen Noureddin, Rohit Loombahttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcld.65, http://onlinelibrary.wiley.com/wol1/doi/10.1002/cld.65/fullpdf
Nonalcoholic Fatty Liver Disease - An Update10.5772/intechopen.880412019Introductory Chapter: Nonalcoholic Fatty Liver Disease - What Should We Know?Emad Hamdy Gad, Yasmin Kamelhttp://www.intechopen.com/download/pdf/68011
Clinical and Molecular Hepatology10.3350/cmh.2022.0442202329Suppls86-s102Nonalcoholic fatty liver disease and non-liver comorbiditiesRichie Manikat, Mindie H. Nguyenhttp://e-cmh.org/upload/pdf/cmh-2022-0442.pdf, http://e-cmh.org/journal/view.php?doi=10.3350/cmh.2022.0442, http://e-cmh.org/upload/pdf/cmh-2022-0442.pdf
Clinical and Molecular Hepatology10.3350/cmh.2023.00662023292384-389Implications of comorbidities in nonalcoholic fatty liver diseaseSherlot Juan Song, Vincent Wai-Sun Wonghttp://e-cmh.org/upload/pdf/cmh-2023-0066.pdf, http://e-cmh.org/journal/view.php?doi=10.3350/cmh.2023.0066, http://e-cmh.org/upload/pdf/cmh-2023-0066.pdf
Digestive and Liver Disease10.1016/j.dld.2018.11.084201951e27Nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) patients with advanced liver disease had high burden of comorbidities, healthcare resource utilization (HCRU) and costs: results from Italian administrative databasesG. Marchesini, J. Ting, S. Saragoni, L. Degli Esposti, A.B. Ozbay, S. Pettahttps://api.elsevier.com/content/article/PII:S1590865818313550?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1590865818313550?httpAccept=text/plain
Nonalcoholic Fatty Liver Disease - An Update10.5772/intechopen.857802019The Rise in the Prevalence of Nonalcoholic Fatty Liver Disease and Hepatocellular CarcinomaZaki A. Sherifhttp://www.intechopen.com/download/pdf/68253
Clinical Liver Disease10.1002/cld.27201214112-113Natural history of nonalcoholic fatty liver diseaseRohini Mehta, Zobair M. Younossihttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcld.27, http://onlinelibrary.wiley.com/wol1/doi/10.1002/cld.27/fullpdf